Enhanced Renal Toxicity Screening: Integrating EpiKidney™ with Live- Cell Analysis
- Drug-and chemical-induced nephrotoxicity often leads to compound failure during development and post-market drug withdrawals due to limitations in traditional animal study methods for predicting human responses
- EpiKidney™ is a 3D human-based in vitro platform that accurately predicts nephrotoxicity by offering a more physiological solution, enhancing the reliability of preclinical evaluations
- The platform integrates with Live-Cell Analysis for streamlined dose-range assessments, simplifying toxicity quantification and providing real-time insights into renal injury, thereby improving understanding of drug effects on human kidney tissue